Fytotherapie‎ > ‎

Leverplanten

Een interessant overzicht van de planten met een werking op de lever, vinden we in het volgend artikel

A phytotherapeutic approach to modern drug development can provide  many invaluable drugs from traditional medicinal plants. Search for pure phytochemicals as drugs is time consuming and expensive. Numerous  plants and polyherbal formulations are used for the treatment of liver diseases. However, in most of the severe cases, the treatments are not  satisfactory. Although experimental evaluations were carried out on a  good number of these plants and formulations, the studies were mostly incomplete and insufficient. 
The therapeutic values were tested against  a few chemicals-induced subclinical levels of liver damages in rodents.  Even common dietary antioxidants can provide such protection from  liver damage caused by oxidative mechanisms of toxic chemicals.  However, experiments have clearly shown that plants such as
Picrorrhiza kurroa, Andrographis paniculata, Eclipta alba, Silibum  marianum, Phyllanthus maderaspatensis and Trichopus zeylanicus are sufficiently active against, at least, certain hepatotoxins.
Screening plants for antihepatitis activities remains in its infancy. P.kurroa, E. alba,  Glycyrrhiza glabra, A. paniculata and P. amarus are likely to be active  against Hepatitis B virus. In the case of severe liver damage, most of the  liver cells die or turn into fibrotic state. In this case, the treatment  should include in addition to the therapeutic agents, agents which can  stimulate liver cell proliferation. For developing satisfactory herbal  combinations to treat severe liver diseases, plants have to be evaluated  systematically for properties such as antiviral activity (Hepatitis B,  Hepatitis C, etc), antihepatotoxicity (antioxidants and others), stimulation of liver regeneration and choleretic activity. The plants with  remarkable activities for each of the above properties have to be identified. Single plant may not have all the desired activities. A  combination of different herbal extracts/'fractions is likely to provide  desired activities to cure severe liver diseases. Development of such  medicines with standards of safety and efficacy can revitalise treatment  of liver disorders and hepatoprotective activity.

Comments